Stocks | Great Portfolio

GrowLife, Inc. Reports Increased Revenue Over Last Quarter and $1 Million in Backlog, in Q2 2020 Financial Results Filing

Portfolio Advisor September 19, 2020September 22, 2020

Company Files Quarterly Report on Financial and Operations Results from the Period Ending June 30, 2020 Summary: GrowLife experienced revenue growth of 11% quarter-over-quarter in the second quarter of 2020 as compared to the first quarter of 2020, from $1.7M to $1.8M GrowLife increased its blended gross margins to 39.3%

Advisor Companies Investing Portfolio Stocks

GrowLife, Inc. Reports Increase in Quarter-Over-Quarter Revenue and Gross Margins for Q1 2020

Portfolio Advisor May 30, 2020June 9, 2020

GrowLife experienced revenue growth of 12.8% quarter-over-quarter in first quarter of 2020 as compared to the fourth quarter of 2019, from $1,473k to $1,661k.GrowLife increased its blended gross margins to 39.3% for the period ending March 31, 2020, up from the fourth quarter of 2019 and last year’s overall which

Advisor Business Companies Investing Portfolio Stocks

GrowLife, Inc. Reports 80% Increase in Year-Over-Year Revenue in 2019 Financial Results and Operational Highlights Filing

Portfolio Advisor May 3, 2020June 9, 2020

GrowLife experienced revenue growth of 80% year-over-year in 2019 as compared to year-end 2018, to $8,218k from $4,573k GrowLife increased gross profit over 444% year-over-year in 2019 as compared to year-end 2018, to $2,549k from $468k GrowLife increased profit margin to 31% at year-end 2019 from 10.2% at year-end 2018

Advisor Business Companies Investing Portfolio Stocks

Aurora Cannabis Announces Second Quarter 2020 Results

Portfolio Advisor April 1, 2020April 1, 2020

Net Revenue of $66.6 million, excluding provisions of $10.6 million Net Cannabis Revenue, excluding provisions, of $63.2 million, In Line With Recent Guidance Cash Cost to Produce Per Gram Sold of $0.88 Successful Launch of Cannabis 2.0 Products Across Canada Consumer Cannabis Net Revenue, excluding provisions, Grows at 11% Over Prior Quarter NYSE |

Advisor Business Companies Investing Portfolio Stocks

Hemp, Inc. Applauds Research Surrounding the Antiviral Potential of Cannabis Compounds

Portfolio Advisor March 26, 2020March 31, 2020

Las Vegas, NV, March 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today that it is supportive of the research

Advisor Business Companies Investing Portfolio Stocks

Carnival Corporation & plc Reports Summary First Quarter Results and Other Matters

Portfolio Advisor March 20, 2020April 1, 2020

MIAMI (March 19, 2020) - Carnival Corporation & plc (the “Corporation”) (NYSE/LSE: CCL; NYSE: CUK) disclosed summary financial information for the quarter ended February 29, 2020, in connection with previously disclosed financing activities to improve its liquidity position. First Quarter 2020 Summary Information U.S. GAAP net loss of $(781) million,

Advisor Business Companies Investing Markets Stocks

GrowLife Increases Revenue By 141% Year-Over-Year Quarterly Growth

Portfolio Advisor November 14, 2019November 19, 2019

GrowLife Continues to Increase Revenue By 141% Year-Over-Year Quarterly Growth Third Quarter Results show $2,299K revenue over last year's $954K Summary: -- GrowLife reports revenue of $6.7 million for the nine months ending as compared to revenue of $2.9 million for the same period in 2018, an increase of 134%

Advisor Business Companies Investing Markets Portfolio Stocks

GrowLife CEO Releases Details on CBD Hemp Clone Sales Strategy

Portfolio Advisor September 13, 2019September 13, 2019

Why We Decided to Expand Growlife/EZ Clone Into the CBD-Rich Hemp Clone Business Starting in 2020 The CBD product industry projected to be $24 billion CBD market with 700% growth with a broken link in the supply chainIndustry-wide lack of CBD-rich hemp clones needed to fulfill demand for consumer productsGrowLife to leverage

Advisor Business Companies Investing Markets Portfolio Stocks

GrowLife Plans to Enter CBD-Rich Hemp Cloning Market, to Start Selling Clones by Next Year

Portfolio Advisor September 5, 2019September 5, 2019

Company Reaches Financing Agreement for $2.5 million, Enabling the Company to Bring Proprietary Hemp Clones to Market Through EZ-CLONE Summary: GrowLife to leverage subsidiary EZ-CLONE expertise by adding CBD-rich hemp clones to product offering, eyeing large market opportunity driven by lack-of-supply of hemp clones Company reaches definitive agreement for equity

Advisor Business Companies Investing Portfolio Stocks

GrowLife, Inc. to Exhibit at MJBizCon International in Toronto

Portfolio Advisor September 3, 2019September 5, 2019

Company subsidiary EZ-CLONE to attend the coveted international industry event on Sept. 4-6, 2019, at booth #105 KIRKLAND, Wash. — GrowLife, Inc. (PHOT), one of the nation’s leading plant cultivation and cannabis/hemp cloning solution providers, announced today the Company will exhibit at MJBizCon International September 4-6, 2019 in Toronto, Ontario